- October 19, 2016Read more
A new collaboration between Cohen Veterans Bioscience and Stanford University School of Medicine announced today, seeks to change this by studying clinical biomarkers as a way to help match patients to the best available treatment.
- October 10, 2016Read more
Suppose that a million or more members of the US Armed Forces and veterans were suffering from an epidemic that could not be prevented, treated or cured — and 20 of them were dying from it every day. Would we address it as a national emergency, mobilizing resources, coordinating research, and insisting on answers?
They are — but we aren’t. It’s time for that to change.
CDISC and Cohen Veterans Bioscience Partner to Establish the First Therapeutic Area Standard for PTSDOctober 5, 2016Read more
The Clinical Data Interchange Standards Consortium (CDISC) and Cohen Veterans Bioscience today announced a collaboration to establish a new CDISC Therapeutic Area Data Standard for post- traumatic stress disorder (PTSD).
Cohen Veterans Bioscience CEO & President Magali Haas, MD, PhD, has been named one of the 100 most inspiring people in the life sciences sector by PharmaVOICEAugust 15, 2016Read more
“A change-maker dedicated to revolutionizing care for brain disease” – our President and CEO Magali Haas has been named one of the 100 most inspiring people in the life sciences sector by PharmaVOICE.
- April 6, 2016Read more
The Cohen Veterans Network (“CVN”) has formally launched operations to offer free, high-quality, comprehensive mental health care to our nation’s veterans and their families, CVN Founder Steven A. Cohen and Executive Director Dr. Anthony Hassan said today.